Just took a glance at the current outstanding share count. Yep, they have 'quietly' been selling shares, up from what was it 11 Mil after the r/split, now at 25 Mil outstanding, with a market cap of $189 Mil.
Guessing this is going to put a 'dent' in the expected share price, might cap it out around $20/sh instead of maybe double that at 14 Mil outstanding.. (last share count I was aware of)...
So what does it do on the 'news'? Who the heck knows now with approx a year from the data release to a potential FDA decision date. And a weak market..
Just not as 'attractive' as it was with 14 Mil shares outstanding.. but the way it goes..